	Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. Am J Transl Res Shi L, He X, Hu Y, Rong Y, Xi J. PMID: 42631165 [PubMed]
	[Translated article] Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis. Farm Hosp Rodríguez Esquíroz A, Garjón Parra J, Echeverría Gorriti A, Sanz Álvarez L, Marín Marín M, Aguinaga Ontoso I. PMID: 42629217 [PubMed - as supplied by publisher]
	Carvedilol Continues to Win: A Target Trial Emulation Study Comparing Carvedilol Against Other Nonselective B-Blockers in Cirrhosis. Gastroenterology Liu A. PMID: 42628812 [PubMed - as supplied by publisher]
	Aspects of implementing a nurse-based follow-up of patients with liver cirrhosis: A qualitative study. PLoS One Hjorth M, Forsberg A. PMID: 42627780 [PubMed - indexed for MEDLINE]
	Intrahepatic Platelets Orchestrate Microenvironmental Remodelling and Cellular Crosstalk in Liver Fibrosis. Liver Int Chen Z, Li H, Ji Q, Gao R, Zhang W, Wu W, Pan Z, Ma H, Wang C, You H, Chen W. PMID: 42627112 [PubMed - indexed for MEDLINE]
	Decoding fibroblast activation: Transcriptional networks in hepatic stellate cells and across fibrotic organs (Review). Int J Mol Med Charoenthanakitkul D, Ariyachet C. PMID: 42627051 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Revisiting salt restriction in hyponatremic cirrhosis - a paradigm in need of refinement? World J Methodol Zou CL. PMID: 42626170 [PubMed]
	Integrated biomarkers and renal Doppler for early acute kidney injury diagnosis in hepatitis C virus cirrhosis. World J Nephrol Othman AAA, Mohamed MM, Eladl MM, Elsayed FMA. PMID: 42626007 [PubMed]
	Development and validation of a machine learning-based model for identifying liver fibrosis in individuals with prior Schistosoma japonicum infection: a step toward precision management. Infect Dis Poverty Wang T, Jiang Y, Zhang J, Li W, Xue H, Hua H, Wang W, Yang K. PMID: 42625218 [PubMed - indexed for MEDLINE]
	Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark. Dig Dis Sci Souza M. PMID: 42625090 [PubMed - as supplied by publisher]
	ROTEM-guided blood product transfusion in patients with cirrhosis having invasive procedures: a randomized controlled trial. Clin Gastroenterol Hepatol Janko N, Kemp W, Strasser SI, Robertson M, Mohammadi F, Sawhney R, Majumdar A, Waller K, MacQuillan G, Goodwin T, Gow P, Hogan C, Nandurkar H, Majeed A, Roberts SK. PMID: 42624392 [PubMed - as supplied by publisher]
	The rate of and risk factors for falls among patients with cirrhosis: A multicenter study. Hepatol Commun Obayemi JE, Paukner M, Hasjim BJ, Vitello D, Barrios PA, Hussain S, Balbale S, VanWagner LB, Mohammadi M, Mehrotra S, Dentici O, Zhao L, Ladner DP, CAPriCORN Team. PMID: 42623523 [PubMed - indexed for MEDLINE]
	Association of non-selective Î² blockers with the mortality risk in decompensation cirrhosis: a systematic review and meta-analysis. Front Pharmacol Zhang J, Lin Y, Weng X. PMID: 42620803 [PubMed]
	Impact of ascitic fluid polymorphonuclear cell counts on development of spontaneous bacterial peritonitis in patients with cirrhosis and ascites: A prospective observational study. Saudi J Gastroenterol Jha SK, Roy S, Agarwal GK, Ashraf B, Kumar R. PMID: 42617031 [PubMed - as supplied by publisher]
	CIRRHOSIS-ASSOCIATED SARCOPENIA: INTEGRATING IMAGING, FUNCTION, AND METABOLISM FOR CLINICAL DECISION-MAKING. Arq Gastroenterol Campeche-Leão ACM, Arruda MR, Batista ACV, Garcez LS, Jesus RP, Cotrim HP, Cavalcante LN. PMID: 42615756 [PubMed - indexed for MEDLINE]
	Naltrexone Is Superior to Placebo for Abstinence and Craving Reduction in Alcohol-Associated Cirrhosis: NAL-CI Trial. Liver Int Alla M, Varshney M, Bhardwaj A, Kumar G, Shasthry SM, Sarin SK. PMID: 42615276 [PubMed - indexed for MEDLINE]
	Short-Term Impact of Fine Particulate Matter on Hepatic Decompensation in Cirrhosis: A Nationwide Case-Crossover Study. Gut Liver Park Y, Kang S, Nam J, Lee J, Woo H, Kim H, Kang SW, Cho J, Kang D, Gwak GY. PMID: 42615186 [PubMed - as supplied by publisher]
	Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study. J Clin Exp Hepatol De A, Duseja A, Mehta M, Singh SP, Shalimar, Mukewar S, Mukewar S, Kar S, Goyal O, Venkataraman J, Devadas K, Dixit VK, Mehta V, Maiwal R, Ranjan P, Nagral A, Choudhary NS, Arora A, Praharaj D, Sharma B, Valsan A, Dadhich S, Nijhawan S, Roy A, Rao PN, Shukla A, Asati P, Gupta R, Saigal S, Narayanasamy K, Mehta R, Bhattacharya M, Prasad VGM, Koshy A, Rastogi M, Alam S, Sanyal AJ, ICON-D Study group. PMID: 42614762 [PubMed]
	Opioid type, rather than liver function, is associated with postoperative nausea and vomiting after painless gastroscopy in decompensated cirrhosis. Front Pharmacol Gu XY, Cao JF, Zhang XY, Jiang LQ. PMID: 42614213 [PubMed]
	A New Nomogram for Mortality Prediction Within 5â€‰Years in Portal Vein Thrombosis due to Hepatitis B-Related Cirrhosis. J Viral Hepat Zhou Y, Xiong F, Chen J, Liu X, Meng P, Wu T, Yu H, Ji X, Jiang Y, Hou Y. PMID: 42613686 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39151

Page 1 of 1958



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy